Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients.
De Cremoux P, Grandin L, Diéras V, Savignoni A, Degeorges A, Salmon R, Bollet MA, Reyal F, Sigal-Zafrani B, Vincent-Salomon A, Sastre-Garau X, Magdelénat H, Mignot L, Fourquet A; Breast Cancer Study Group of the Institut Curie. De Cremoux P, et al. Among authors: savignoni a. Anticancer Res. 2009 May;29(5):1475-82. Anticancer Res. 2009. PMID: 19443353 Free article.
Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment.
Bollet MA, Savignoni A, De Koning L, Tran-Perennou C, Barbaroux C, Degeorges A, Sigal-Zafrani B, Almouzni G, Cottu P, Salmon R, Servant N, Fourquet A, de Cremoux P. Bollet MA, et al. Among authors: savignoni a. Breast Cancer Res. 2009;11(4):R54. doi: 10.1186/bcr2343. Epub 2009 Jul 28. Breast Cancer Res. 2009. PMID: 19638208 Free PMC article.
[HRT in post menopausal women and breast cancer at the Institut Curie].
Czernichow C, This P, Asselain B, Falcou MC, Savignoni A, Salmon RJ; Groupe sein de l'Institut Curie; Sigal-Zafrani B. Czernichow C, et al. Among authors: savignoni a. Bull Cancer. 2007 May;94(5):469-75. Bull Cancer. 2007. PMID: 17535785 Free article. French.
Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy.
Kirova YM, Campana F, Savignoni A, Laki F, Muresan M, Dendale R, Bollet MA, Salmon RJ, Fourquet A; Institut Curie Breast Cancer Study Group. Kirova YM, et al. Among authors: savignoni a. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):76-81. doi: 10.1016/j.ijrobp.2008.11.005. Epub 2009 Jan 23. Int J Radiat Oncol Biol Phys. 2009. PMID: 19168297
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.
Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A. Kirova YM, et al. Among authors: savignoni a. Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033769 Review.
Management of inflammatory breast cancer after neoadjuvant chemotherapy.
Abrous-Anane S, Savignoni A, Daveau C, Pierga JY, Gautier C, Reyal F, Dendale R, Campana F, Kirova YM, Fourquet A, Bollet MA. Abrous-Anane S, et al. Among authors: savignoni a. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1055-63. doi: 10.1016/j.ijrobp.2009.12.009. Epub 2010 May 17. Int J Radiat Oncol Biol Phys. 2011. PMID: 20478662
The impact of the loco-regional treatment in elderly breast cancer patients: hypo-fractionated exclusive radiotherapy, single institution long-term results.
Chargari C, Kirova YM, Laki F, Savignoni A, Dorval T, Dendale R, Bollet MA, Fourquet A, Campana F; Institut Curie Breast Cancer Study Group. Chargari C, et al. Among authors: savignoni a. Breast. 2010 Oct;19(5):413-6. doi: 10.1016/j.breast.2010.04.004. Epub 2010 May 18. Breast. 2010. PMID: 20483616 Free article.
95 results